Cytoreductive Surgery: Why, When, & How often?
The Carcinoid Cancer Foundation recently presented a Live Q&A session with Dr. Xavier Keutgen, discussing surgery for people living with neuroendocrine…READ MORE
June Luncheon with the Experts in New York City for the Neuroendocrine Tumor Community
Join neuroendocrine tumor (NET) patients in New York City on Sunday, June 10, 2018 for a unique opportunity to have lunch with two medical experts. Share your experiences with others who have similar concerns and hear from physicians on issues ranging…READ MORE
Go Zebra-Striped for NET Cancer Day
We’re incredibly excited to share our app worldwide to raise awareness of carcinoid and neuroendocrine cancers on and around NET Cancer Day, November 10, and throughout the year. Follow the directions here, https://www.carcinoid.org/go-zebra-striped/…READ MORE
Neuroendocrine Tumors to Be Focus of Presentations and Posters at ASCO Gastrointestinal Cancers Symposium
Presentations on recent advances in the treatment of neuroendocrine tumors (NETs) and new findings from the NETTER-1 clinical study on PRRT with Lutathera along with posters on a wide variety of subjects about NETs will be part of the program during the…READ MORE
Intelligent Patients — Just What the Doctor Didn’t Order by Ronny Allan
The Carcinoid Cancer Foundation is pleased to announce that we are going to feature guest contributors to our blog during 2015. Intelligent Patients – Just What the Doctor Didn’t Order by Ronny Allan (pictured), a carcinoid cancer patient from the UK,…READ MORE
North Carolina Golf Tournament Raises Awareness of Carcinoid Cancer and Funds for the Carcinoid Cancer Foundation
Larry Sanders, Plant Engineer at Arclin USA in Moncure, North Carolina, and his colleagues held the Arclin’s Men and Women’s Golf Tournament on May 24, 2014 to express appreciation for those who work at the plant and for Arclin’s clients and to raise awareness…READ MORE
Call for Nominations: 2014 Warner Advocacy Award
Do you know someone who is a passionate advocate for patients with neuroendocrine tumors (NETs)? The NET Alliance™ and Novartis Oncology have announced the 2014 Warner Advocacy Award, named in honor of the late Monica Warner, a driving force behind the…READ MORE
Novartis Offers New Sandostatin LAR Depot Co-Pay Assistance Program
A new co-pay assistance program for carcinoid syndrome patients taking Sandostatin® LAR Depot has been established by Novartis Pharmaceuticals Corporation, effective February 2014.
With the Sandostatin® LAR Depot Co-Pay Assistance Program, eligible…READ MORE
Multiple Endocrine Neoplasia (MEN) Patient and Family Seminar in Chicago
Multiple Endocrine Neoplasia 1 and 2 patients and their families are invited to a free, half-day education seminar on Saturday, March 22, 2014, presented by the Lurie Cancer Center of Northwestern University in Chicago, Illinois and American Multiple…READ MORE
Mobile Survey for Carcinoid Syndrome Community
Carcinoid syndrome patients, caregivers, and advocates in the carcinoid syndrome community are invited to participate in an exclusive mobile survey being conducted by WEGO Health via Truvio.
WEGO Health is an organization committed to empowering…READ MORE